10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0000721371-19-000010`
Period End Date	20181231
Filing Date	20190207
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	cah-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 88 Cash Flow Statement 76 Comprehensive Income 28

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.18B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.25B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.88B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$7.80B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$7.93B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	18.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$13.04B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	29.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$12.31B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.93B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.94B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	$756.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.55B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.09B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.38B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.49B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$12.23B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$11.97B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$682.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.02B	USD	Point-in-time
Total assets	`Assets`	$39.95B	USD	Point-in-time
Total assets	`Assets`	$40.46B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$19.68B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$20.61B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.00B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.45B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$1.76B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.00B	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	$213.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$22.89B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.82B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$7.60B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$8.01B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$3.00B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$2.98B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$12.00M	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued[327 million] shares at December 31, 2018 and June 30, 2018, respectively	`CommonStockValue`	$2.73B	USD	Point-in-time
Authorized755 million shares, Issued[327 million] shares at December 31, 2018 and June 30, 2018, respectively	`CommonStockValue`	$2.73B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.64B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.23B	USD	Point-in-time
Common shares in treasury, at cost: [0 million] shares and 18 million shares at December 31, 2018 and June 30, 2018, respectively	`TreasuryStockValue`	$1.79B	USD	Point-in-time
Common shares in treasury, at cost: [0 million] shares and 18 million shares at December 31, 2018 and June 30, 2018, respectively	`TreasuryStockValue`	$1.22B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-123.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-92.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.04B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and shareholders equity	`LiabilitiesAndStockholdersEquity`	$40.46B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and shareholders equity	`LiabilitiesAndStockholdersEquity`	$39.95B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$72.95B	USD	2 Qtrs
Revenue	`Revenues`	$67.83B	USD	2 Qtrs
Revenue	`Revenues`	$35.19B	USD	1 Quarter
Revenue	`Revenues`	$37.74B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$36.01B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$69.56B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$64.29B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$33.33B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.40B	USD	2 Qtrs
Gross margin	`GrossProfit`	$3.53B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.86B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.73B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.13B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.22B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.19B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.06B	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$12.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$21.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$44.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$153.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$314.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$368.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$184.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$157.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-68.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-68.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$503.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-90.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$15.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-58.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-3.00M	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$1.32B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$661.00M	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$504.00M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$399.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-21.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-25.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$5.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$4.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$152.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$168.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$87.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$76.00M	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$495.00M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.14B	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$407.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$317.00M	USD	1 Quarter
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$269.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-675.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-736.00M	USD	1 Quarter
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$126.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$874.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$1.17B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$1.05B	USD	1 Quarter
Net earnings	`ProfitLoss`	$281.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$280.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$873.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$1.05B	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$1.17B	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$3.35	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.90	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$3.70	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.94	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.93	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$3.68	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$3.33	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$2.88	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	299.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	302.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	315.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	315.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	316.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	300.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	317.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	303.00M	shares	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.95	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.46	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.92	USD	2 Qtrs

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$874.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$1.17B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$1.05B	USD	1 Quarter
Net earnings	`ProfitLoss`	$281.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$520.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$498.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on Sale of Investments	`LossOnSaleOfInvestments`	$2.00M	USD	2 Qtrs
Loss on Sale of Investments	`LossOnSaleOfInvestments`	$6.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-68.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-68.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$503.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$41.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$40.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$40.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$31.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$191.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$617.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$753.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$995.00M	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$941.00M	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.11B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$213.00M	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$870.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$736.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.46B	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.14B	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$21.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$168.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$116.00M	USD	2 Qtrs
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$10.00M	USD	2 Qtrs
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$6.00M	USD	2 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	2 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$65.00M	USD	2 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	-	USD	2 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	$1.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	$740.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.25B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$595.00M	USD	2 Qtrs
Payment for Contingent Consideration Liability, Financing Activities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$17.00M	USD	2 Qtrs
Payment for Contingent Consideration Liability, Financing Activities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$155.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Purchase of noncontrolling interests	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	$106.00M	USD	2 Qtrs
Purchase of noncontrolling interests	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	-	USD	2 Qtrs
Proceeds from Issuance of Long-term Debt and Capital Securities, Net	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	-	USD	2 Qtrs
Proceeds from Issuance of Long-term Debt and Capital Securities, Net	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$3.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$403.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$2.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-16.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-13.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$296.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$293.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$150.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$600.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-908.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-830.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-4.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$7.00M	USD	2 Qtrs
CashReclassifiedtoAssetsHeldforSale	`CashReclassifiedtoAssetsHeldforSale`	$-18.00M	USD	2 Qtrs
CashReclassifiedtoAssetsHeldforSale	`CashReclassifiedtoAssetsHeldforSale`	-	USD	2 Qtrs
Net decrease in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$419.00M	USD	2 Qtrs
Net decrease in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-5.63B	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.18B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.25B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.88B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.18B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.25B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.88B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$874.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$1.17B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$1.05B	USD	1 Quarter
Net earnings	`ProfitLoss`	$281.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-29.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$31.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-26.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-9.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	-	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-2.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$30.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-27.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$843.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.20B	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$254.00M	USD	1 Quarter
Net Income (Loss) Attributable to Noncontrolling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net Income (Loss) Attributable to Noncontrolling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Noncontrolling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net Income (Loss) Attributable to Noncontrolling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$253.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$1.20B	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$1.04B	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$842.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.